Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
ContributorsBoonen, Steven; Reginster, Jean-Yves; Kaufman, Jean-Marc; Lippuner, Kurt; Zanchetta, Jose; Langdahl, Bente; Rizzoli, René; Lipschitz, Stanley; Dimai, Hans Peter; Witvrouw, Richard; Eriksen, Erik; Brixen, Kim; Russo, Luis; Claessens, Frank; Papanastasiou, Philemon; Antunez, Oscar; Su, Guoqin; Bucci-Rechtweg, Christina; Hruska, Josef; Incera, Elodie; Vanderschueren, Dirk; Orwoll, Eric
Published inThe New England journal of medicine, vol. 367, no. 18, p. 1714-1723
Publication date2012
Research groups
Citation (ISO format)
BOONEN, Steven et al. Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis. In: The New England journal of medicine, 2012, vol. 367, n° 18, p. 1714–1723. doi: 10.1056/NEJMoa1204061
Main files (1)
Article (Published version)
Identifiers
- PID : unige:28832
- DOI : 10.1056/NEJMoa1204061
- PMID : 23113482
Journal ISSN0028-4793
